CohBar, Morphogenesis link up in reverse merger of two cancer biotechs

The cancer-focused Bay Area biotech CohBar is entering into a reverse merger with the privately-held biotech Morphogenesis. On Tuesday, CohBar and Morphogenesis announced the all-stock transaction. The newly combined company will operate under the name TuHURA Biosciences and trade on the Nasdaq. The deal is expected to close in the…

...

Click to view original post